1636: The Superior Beneficial Effect of Combination Therapy with Doxazosin and Finasteride Versus Either Drug Alone on Clinical Progression of Benign Prostatic Hyperplasia is not Dependent on Patients Having Prostatic Enlargement at Baseline: Data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial

You have accessJournal of UrologyPodium, Wednesday, May 25, 2005, 1:00 - 3:00 pm1 Apr 20051636: The Superior Beneficial Effect of Combination Therapy with Doxazosin and Finasteride Versus Either Drug Alone on Clinical Progression of Benign Prostatic Hyperplasia is not Dependent on Patients Having Prostatic Enlargement at Baseline: Data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial Steven A. Kaplan, Claus G. Roehrborn, and Michael W. Lee Steven A. KaplanSteven A. Kaplan More articles by this author , Claus G. RoehrbornClaus G. Roehrborn More articles by this author , and Michael W. LeeMichael W. Lee More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)35758-6AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "1636: The Superior Beneficial Effect of Combination Therapy with Doxazosin and Finasteride Versus Either Drug Alone on Clinical Progression of Benign Prostatic Hyperplasia is not Dependent on Patients Having Prostatic Enlargement at Baseline: Data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial." The Journal of Urology, 173(4S), p. 443 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 173Issue 4SApril 2005Page: 443 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Steven A. Kaplan More articles by this author Claus G. Roehrborn More articles by this author Michael W. Lee More articles by this author Expand All Advertisement Loading ...